Chemed Corp. (CHE) Misses Q3 EPS by 7c; Guides FY12 EPS Below Consensus
Tweet
Share
E-mailGet Alerts CHE Hot Sheet
Price: $465.74 +1.27%
EPS Growth %: +31.6%
Financial Fact:
Interest expense: -1.02M
Today's EPS Names:
DTGI, CRMT, STZ, More
EPS Growth %: +31.6%
Financial Fact:
Interest expense: -1.02M
Today's EPS Names:
DTGI, CRMT, STZ, More
Join SI Premium – FREE
Chemed Corp. (NYSE: CHE) reported Q3 EPS of $1.28, $0.07 worse than the analyst estimate of $1.35. Revenue for the quarter came in at $354 million versus the consensus estimate of $360.5 million.
Chemed Corp. sees FY2012 EPS of $5.20-5.30, versus the consensus of $5.37.
For earnings history and earnings-related data on Chemed Corp. (CHE) click here.
Chemed Corp. sees FY2012 EPS of $5.20-5.30, versus the consensus of $5.37.
For earnings history and earnings-related data on Chemed Corp. (CHE) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Constellation Brands (STZ) Tops Q1 EPS by 18c
- Halozyme names David Ramsay as president of drug delivery
- Papa Johns names interim CFO as Ravi Thanawala departs
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
